Phobia Complex
FDA Label NDC 52731-7042

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Nova Homeopathic Therapeutics, Inc. for the product Phobia Complex (NDC 52731-7042). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding purpose:, usage and dosage:, dosage & administration, warnings:, warnings, active ingredients:, inactive ingredients:, otc - questions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

→ Purpose:

→ Usage And Dosage:

→ Dosage & Administration

→ Warnings:

→ Warnings

→ Active Ingredients:

→ Inactive Ingredients:

→ Otc - Questions

→ Package Label.principal Display Panel

Purpose:

Suggested use for one or more of the following symptoms:

Fear of elevators, enclosed spaces, airplanes, crowds, wide open spaces, buildings.

Usage And Dosage:

For oral use only.

Dosage & Administration

Adults:

    In Acute Phase:
            12-15 drops, every half hour until relief occurs
    When Relief Occurs:
            12-15 drops, 4-6 times per day

Children 2-12 years:

           8-10 drops, 4-6 times per day